TP53 and ovarian cancer: Furthermore, the absence of FGL2 leads to prolonged survival in the B16F10 melanoma model, while the absence of FGL2 synergizes with oncolytic virus to prolong survival in the ID8-p53−/−Brca2−/− ovarian cancer model.